These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26491516)

  • 1. [Molecular diagnosis of Mycobacterium tuberculosis complex resistant to isoniazid and rifampicin in Burkina Faso].
    Désire I; Cyrille B; Florencia D; Souba D; Albert Y; Valerie BJ; Rebecca C; Charlemagne G; Tamboura D; Rémy M; Virginio P; Simplice KD; Martial O; Jacques S
    Pan Afr Med J; 2015; 21():73. PubMed ID: 26491516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance of Mycobacterium tuberculosis complex among newly diagnosed tuberculosis cases in Burkina Faso.
    Diandé S; Sangaré L; Kouanda S; Dingoumda BI; Traoré AS
    West Afr J Med; 2009; 28(6):353-7. PubMed ID: 20486091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
    Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin resistance in tuberculosis outbreak, London, England.
    Jenkins C
    Emerg Infect Dis; 2005 Jun; 11(6):931-4. PubMed ID: 15963290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    Hundie GB; Woldemeskel D; Gessesse A
    PLoS One; 2016; 11(12):e0169188. PubMed ID: 28030634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 10. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey.
    Tahaoğlu K; Kizkin O; Karagöz T; Tor M; Partal M; Sadoğlu T
    Tuber Lung Dis; 1994 Oct; 75(5):324-8. PubMed ID: 7841424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmissibility and potential for disease progression of drug resistant
    Becerra MC; Huang CC; Lecca L; Bayona J; Contreras C; Calderon R; Yataco R; Galea J; Zhang Z; Atwood S; Cohen T; Mitnick CD; Farmer P; Murray M
    BMJ; 2019 Oct; 367():l5894. PubMed ID: 31649017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Sharma S; Madan M; Agrawal C; Asthana AK
    Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?
    Badoum G; Saleri N; Dembélé MS; Ouedraogo M; Pinsi G; Boncoungou K; Bonkoungou V; Birba E; Miotto P; Migliori GB; Cirillo DM; Matteelli A
    Eur Respir J; 2011 May; 37(5):1283-5. PubMed ID: 21532018
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.
    Ndung'u PW; Kariuki S; Ng'ang'a Z; Revathi G
    J Infect Dev Ctries; 2012 Jan; 6(1):33-9. PubMed ID: 22240426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan.
    Farooqi JQ; Khan E; Alam SM; Ali A; Hasan Z; Hasan R
    J Pak Med Assoc; 2012 Aug; 62(8):767-72. PubMed ID: 23862246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of short-course therapy on tuberculosis drug resistance in South-West Burkina Faso.
    Ledru S; Cauchoix B; Yaméogo M; Zoubga A; Lamandé-Chiron J; Portaels F; Chiron JP
    Tuber Lung Dis; 1996 Oct; 77(5):429-36. PubMed ID: 8959147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Nimri L; Samara H; Batchoun R
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
    Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
    Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia.
    Mekonnen D; Admassu A; Mulu W; Amor A; Benito A; Gelaye W; Biadglegne F; Abera B
    Int J Infect Dis; 2015 Oct; 39():34-8. PubMed ID: 26119857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis.
    Lin D; Wang X; Li Y; Wang W; Li Y; Yu X; Lin B; Chen Y; Lei C; Zhang X; Zhang X; Huang J; Lin B; Yang W; Zhou J; Zeng J; Liu X
    Int J Med Sci; 2021; 18(9):1935-1945. PubMed ID: 33850462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.